Chen Tan1, Li-Jun Zeng2, Hai-Feng Shi3, Ying Tian2, Nan Ma4, Hao Liu4, Sheng-Chao Li1, Xue-Hong Hu1, Ju Mei4, Xing-Peng Liu1,2. 1. Department of Cardiology, Hebei Yanda Hospital, Hebei, Hebei Province, China. 2. Heart Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. 3. Department of Cardiology, Beijing Hospital, Beijing, China. 4. Department of Cardiothoracic Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Abstract
OBJECTIVES: Hybrid catheter and surgical ablation has emerged as an effective therapy for patients with persistent atrial fibrillation (AF). The aims of this study were to evaluate the relationship between intraprocedural arrhythmia termination and the long-term outcomes of hybrid ablation in patients with long-standing persistent AF. METHODS: From May 2015 through April 2019, 50 patients with persistent AF with a mean duration of 73.3 ± 62.1 (median 54) months underwent single-step hybrid ablation. Pulmonary vein isolation, left atrial posterior wall isolation and left atrial appendage excision or closure were performed through a left-sided thoracoscopic approach. Subsequently, all patients underwent high-density endocardial mapping and electrogram-based ablation with the end point of AF termination. RESULTS: We achieved intraprocedural AF termination in 84% (42/50) patients; this end point was reached in 16 patients during surgical ablation and in 26 patients during catheter ablation. Seven patients underwent repeat catheter ablation. After a mean follow-up period of 29 ± 13 months, the freedom from atrial tachyarrhythmia of a single procedure without the use of antiarrhythmic drugs was 70% (35/50). In the Cox regression model, intraprocedural termination of AF (hazard ratio 0.205, 95% confidence interval 0.058-0.730; P = 0.014) was the sole predictor of success. CONCLUSIONS: The 2-year outcomes of a one-stop hybrid ablation with an end point of AF termination are promising in patients with long-standing persistent AF.
OBJECTIVES: Hybrid catheter and surgical ablation has emerged as an effective therapy for patients with persistent atrial fibrillation (AF). The aims of this study were to evaluate the relationship between intraprocedural arrhythmia termination and the long-term outcomes of hybrid ablation in patients with long-standing persistent AF. METHODS: From May 2015 through April 2019, 50 patients with persistent AF with a mean duration of 73.3 ± 62.1 (median 54) months underwent single-step hybrid ablation. Pulmonary vein isolation, left atrial posterior wall isolation and left atrial appendage excision or closure were performed through a left-sided thoracoscopic approach. Subsequently, all patients underwent high-density endocardial mapping and electrogram-based ablation with the end point of AF termination. RESULTS: We achieved intraprocedural AF termination in 84% (42/50) patients; this end point was reached in 16 patients during surgical ablation and in 26 patients during catheter ablation. Seven patients underwent repeat catheter ablation. After a mean follow-up period of 29 ± 13 months, the freedom from atrial tachyarrhythmia of a single procedure without the use of antiarrhythmic drugs was 70% (35/50). In the Cox regression model, intraprocedural termination of AF (hazard ratio 0.205, 95% confidence interval 0.058-0.730; P = 0.014) was the sole predictor of success. CONCLUSIONS: The 2-year outcomes of a one-stop hybrid ablation with an end point of AF termination are promising in patients with long-standing persistent AF.
Authors: Michel Haïssaguerre; Prashanthan Sanders; Mélèze Hocini; Yoshihide Takahashi; Martin Rotter; Frederic Sacher; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs Journal: J Cardiovasc Electrophysiol Date: 2005-11
Authors: Carlo de Asmundis; Gian-Battista Chierchia; Giacomo Mugnai; Ines Van Loo; Jan Nijs; Jens Czapla; Giulio Conte; Vedran Velagic; Moises Rodrigues Mañero; Giuseppe Ciconte; Erwin Ströker; Vincent Umbrain; Jan Poelaert; Pedro Brugada; Mark La Meir Journal: Europace Date: 2016-05-31 Impact factor: 5.214
Authors: Doreen Schreiber; Thomas Rostock; Max Fröhlich; Arian Sultan; Helge Servatius; Boris A Hoffmann; Jakob Lüker; Imke Berner; Benjamin Schäffer; Karl Wegscheider; Susanne Lezius; Stephan Willems; Daniel Steven Journal: Circ Arrhythm Electrophysiol Date: 2015-03-05
Authors: Claudia A J van der Heijden; Mindy Vroomen; Justin G Luermans; Rein Vos; Harry J G M Crijns; Sandro Gelsomino; Mark La Meir; Laurent Pison; Bart Maesen Journal: Eur J Cardiothorac Surg Date: 2019-09-01 Impact factor: 4.191
Authors: Vivek Y Reddy; Scott Pollak; Bruce D Lindsay; H Thomas McElderry; Andrea Natale; Charan Kantipudi; Moussa Mansour; Daniel P Melby; Dhanunjaya Lakkireddy; Tzachi Levy; David Izraeli; Chithra Sangli; David Wilber Journal: JACC Clin Electrophysiol Date: 2016-11-21
Authors: Roland Richard Tilz; Andreas Rillig; Anna-Maria Thum; Anita Arya; Peter Wohlmuth; Andreas Metzner; Shibu Mathew; Yasuhiro Yoshiga; Erik Wissner; Karl-Heinz Kuck; Feifan Ouyang Journal: J Am Coll Cardiol Date: 2012-10-10 Impact factor: 24.094